drugset / Trial / NCT01152658

Partial Tear of Supraspinatus (SSP) and Treatment With Plasma Rich in Growth Factors (PRGF)

NCT01152658 ↗

Phase 1 Withdrawn Meir Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this clinical trial is to evaluate the impact and symptomatic efficacy of platelets rich plasma (PRP \\ PRGF) in the treatment of partial tears of supraspinatus tendon of rotator cuff. Speed of tendon healing of partial thickness tear of the supraspinatus tendon influenced by local injection of platelets rich plasma

Timeline

Start
2010-04
Primary completion
2012-05
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PRGF Unknown — Other

Indications

No indication recorded.